Civitas Has ‘Meaningful’ Scale To Drive FCF & Capital Return, Analyst Asserts
BMO Capital Markets analyst Phillip Jungwirth initiated coverage on Civitas Resources Inc (NYSE: CIVI) with an Outperform rating
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and
Here’s What’s Going On With Microvast Stock Thursday
Microvast Holdings Inc (NASDAQ: MVST) shares are trading higher Thursday after one analyst firm initiated coverage on the stock with a price target of $8.
Benzinga’s Top Ratings Upgrades, Downgrades For August 31, 2023
Upgrades Jefferies upgraded the previous rating for Mesoblast Ltd (NASDAQ:MESO) from Hold to Buy. NoneThe current stock performance…
Benzinga’s Top Ratings Upgrades, Downgrades For August 29, 2023
Upgrades JP Morgan upgraded the previous rating for Noah Holdings Ltd (NYSE:NOAH) from Neutral to Overweight. Noah Holdings…
Benzinga’s Top Ratings Upgrades, Downgrades For August 28, 2023
Upgrades According to B of A Securities, the prior rating for Futu Holdings Ltd (NASDAQ:FUTU) was changed from…
Benzinga’s Top Ratings Upgrades, Downgrades For August 25, 2023
Upgrades For Hibbett Inc (NASDAQ:HIBB), Williams Trading upgraded the previous rating of Hold to Buy. Hibbett earned $0.85…
Small Cancer Player Werewolf Therapeutics’ Stock Undervalued: Analyst Says Treatment Platform Underappreciated
Wedbush initiated coverage on Werewolf Therapeutics Inc (NASDAQ: HOWL) with an Outperform rating and a
eFFECTOR Stock To Rally Over 500%? Analyst Predict Blockbuster Status For Cancer Candidates
HC Wainwright has initiated coverage on eFFECTOR Therapeutics Inc (NASDAQ: EFTR) with a Buy rating
Benzinga’s Top Ratings Upgrades, Downgrades For August 24, 2023
Upgrades UBS upgraded the previous rating for Petroleo Brasileiro SA Petrobras (NYSE:PBR) from Neutral to Buy. In the…